Genomic DNA was extracted from both the peripheral blood leucocytes of enrolled individuals and derived undifferentiated CF-CRC-AESC, using the QIAamp DNA Blood midi kit (Qiagen, Hilden, Germany) and quantified using fluorimetry (Qubit, Invitrogen, CA, USA). The proximal 5′-flanking, all exons and adjacent intronic zones, and the 3′-UTR of the CFTR gene (RefSeq NM_000492.4, NG_016465.4) were sequenced by a Sanger cycle sequencing protocol (ThermoFisher Scientific, Waltham, MA, USA) as previously described [21 (link),22 (link),23 (link)], using a genetic analyzer (ABI PRISM 3130xl; ThermoFisher Scientific). Genetic analysis was completed through multiplex ligation-dependent probe amplification (SALSA MLPA probemix P091 CFTR, MRC Holland, Amsterdam, The Netherlands) to unveil macrodeletions/macroduplications. The genotype of derived undifferentiated CF-CRC-AESC was confirmed using the same methodology. Results of mutational analysis have already been published [5 (link),19 (link)].
Free full text: Click here